Mylan to supply remdesivir in India at Rs 4,800
International pharmaceutical main Mylan NV mentioned that it has acquired the approval of Drug Controller Common of India (DCGI) for launching generic model of anti-coronavirus drug remdesivir. The corporate will roll out 100 mg per vial dosage of remdesivir within the nation at Rs 4,800 for restricted emergency use. “The drug is permitted for the…
Details